rs967624732
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The p.Ala126Thr and p.Val169Ala variants have been reported to have no association with risk of breast cancer in a case-control study.
|
22476429 |
2012 |
rs886040920
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated and found no significant association between the P210L variant and breast cancer risk in a small case-control study of African-American women.
|
21113654 |
2011 |
rs886040898
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs886039958
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Here, we discovered that carriers of both variants, AKAP10 Ile646Val and AKAP13 Lys526Gln, are at a further enhanced breast cancer risk (OR=2.41, 95% CI 1.30-4.46, P=0.005).
|
16956908 |
2007 |
rs886039920
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings establish L35P as the first pathogenic missense mutation in PALB2 and directly demonstrate the requirement of the PALB2-BRCA1 interaction for breast cancer suppression.
|
28319063 |
2017 |
rs886037971
|
|
|
0.010 |
GeneticVariation |
BEFREE |
There was some evidence (two-sided P = 0.09) that 330A>G (R71G) in BRCA1 may have lower breast cancer penetrance.
|
18451254 |
2008 |
rs879255498
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs879255320
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs879255317
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
|
12938098 |
2003 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene.
|
9760198 |
1998 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
|
15133502 |
2004 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
BRCA1 mutations in primary breast and ovarian carcinomas.
|
7939630 |
1994 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.
|
12442275 |
2002 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.
|
7894491 |
1994 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.
|
8776600 |
1996 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.
|
28364669 |
2017 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Mutations in the BRCA1 gene in Japanese breast cancer patients.
|
8723683 |
1996 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
|
7894493 |
1994 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A high-throughput functional complementation assay for classification of BRCA1 missense variants.
|
23867111 |
2013 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.
|
21473589 |
2011 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.
|
14722926 |
2004 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.
|
10323242 |
1999 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
|
12427738 |
2003 |
rs879254042
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
|
18285836 |
2008 |